Last reviewed · How we verify
NCT06132776
The Mamma HiToP Study
NA trial testing HiToP 191 PNP in Chemotherapy-induced Peripheral Neuropathy in 160 participants. Currently enrolling.
2 November 2024
Quick facts
| Lead sponsor | Vienna Hospital Association |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 160 |
| Start date | 3 November 2023 |
| Primary completion | 2 November 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- HiToP 191 PNP
- Placebo device
Conditions studied
- Chemotherapy-induced Peripheral Neuropathy — all drugs for Chemotherapy-induced Peripheral Neuropathy →
Sponsor
Vienna Hospital Association
Who can join
18 and older, any sex, with Chemotherapy-induced Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The HiToP ® 191 PNP an certified device licensed for the treatment of neuropathia. The home-based treatment is to be performed only in accordance with the approved Investigational Plan (CIP) on subjects who have signed an informed consent form. Device use is limited to the approved study investigators. The study is multicenter, randomized, double-blind, and placebo-controlled. Primary Objective: Comparison of the change of paresthesias from baseline until end of therapy between the two patient groups, assessed by questionnaires Secondary Objectives: Further symptoms of neuropathy as well as on health-related quality of life.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Chemotherapy-induced peripheral neuropathy in patients with breast cancer treated with taxanes (Review).
Godiveau M, Jahanmohan JP, Abrial C, Durando X. · · 2025 · cited 2× · PMID 40949893 · DOI 10.3892/ol.2025.15254
Verify or expand the search:
- PubMed search for NCT06132776
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chemotherapy-induced Peripheral Neuropathy
Currently open trials in the same condition.
- NCT07177820 — VGAIT for Chemotherapy-induced Peripheral Neuropathy · NA · recruiting
- NCT07072468 — Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) · Phase 2 · recruiting
- NCT06389721 — Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy · recruiting
- NCT06405542 — Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN) · Phase 1 · active not recruiting
- NCT06162403 — Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longi · NA · recruiting
Other Vienna Hospital Association trials
Trials by the same sponsor.
- NCT05954637 — Correlation of Structure and Function in Glaucoma · completed
- NCT04829955 — Eccentric Manual Resistance Training in Patients With Ischemic CMP · NA · completed
- NCT05058742 — Non-invasive Nervus Vagus Stimulation in Patients With COVID-19 and ARDS · NA · unknown
- NCT06048471 — High Tone Therapy for Chemotherapy Induced Neuropathy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06132776 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vienna Hospital Association
- Last refreshed: 26 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06132776.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing